chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme rash/welts over entire body from head to feet; Extreme rash/welts over entire body from head to feet; This is a spontaneous report from two contactable consumers (patient and patient husband). A 75-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW6200), via an unspecified route of ad-ministration on 24Feb2021 at 10:00 AM in the left arm at single dose for COVID-19 immunisation. The patient age at vaccination was 75 Years. Facility where COVID-19 vaccine was administered was at the other. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included Epstein barr viraemia. Concomitant medications included olmesartan medoxomil (BENICAR) taken for blood pressure measurement and levothyroxine sodium (SYNTHROID) taken for an unspecified indication. Historical vaccine included first dose of BNT162B2 (Lot Number: EL9263), on 03Feb2021 at 09:00 AM in the left arm at single dose for COVID-19 immunisation. On 04Mar2021, the patient experienced extreme rash/welts over entire body from head to feet. Reporter stated, she went to her internist on Friday as a result of the rash that she developed, it's a very serious rash basically from her head to her toes and he put her on Benadryl which did not help and then he gave her Medrol pack which she started yesterday and getting two days worth of the Medrol pack which does not seem to be helping yet. Reporter added, we would like to know, going online we could see this is somewhat not rare side effect any other medication or treatment she should be receiving or what is the experience with respect to the side effect how long does it last. Multiple blood work, they were all within normal limits. Date of Lab work was approximately 3 weeks ago. The adverse event result in Doctor or other healthcare professional office/clinic visit. The patient was not diagnosed with COVID-19 prior to vaccination and not tested for COVID-19, since the vaccination. The patient underwent lab tests and procedures which included blood test: normal on an unknown date 2021 (all within normal limits). Therapeutic measures were taken as a result of extreme rash/welts over entire body from head to feet with Benadryl & Medrol Pak. Outcome of the events was not recovered. Health authority comment: none.  More follow-up information has been requested.
Initial and follow-up information has been received from a physician and a health care professional concerning a 71 year old retired female with asthma and an allergy to the Tetanus vaccine, who on 22-AUG-2007 (previously reported as 15-OCT-2007) was vaccinated intramuscularly in the right deltoid with a first dose of PNEUMOVAX (Lot# 657143/0380U) (previously reported as Lot# 658555/0964).  Concomitant therapy included influenza virus vaccine (unspecified), administered into a different site.  Subsequently, the patient developed pain, swelling, and redness at the injection site.  On 24-AUG-2007 the patient developed 2 reddened areas below the injection site.  The patient experienced pain, soreness, and the area was warm to touch.  The patient reported that the symptoms resolved within 3 days and that he had had 2 or 3 vaccinations with PNEUMOVAX in the past.  The patient had an office visit.  The patient recovered on 25-AUG-2007.  No product quality complaint was involved.  Additional information is not expected.
8/13/07 1105 Pneumococcal vaccine 0.5ml IM given left deltoid. 8/14/07 0500 Redness, swelling of left inner aspect of arm from below under arm to elbow. 8/14/07 Seen by LVN issued Ibuprofen @ 1430. 8/16/07 NP examined arm - Benadryl 50mg BID PRN x 30 days.
She has not experienced any fever, cough, or shortness of breath, and did get the Johnson & Johnson Covid vaccine, but has seen where the single vaccine is not effective against the delta strain and would like to get a Maderna booster.
He reported that his vision was blurry, and that he could see only if he looked with only one eye.  He did state that it has been improving.
Exactly one week after my first shot in my left arm, I developed swelling, redness and a rash at the injection site and upper arm.
Redness, warmth, edema (L) upper arm at injection site - very tender. Afebrile.
Herpes zoster (shingles) on forehead and scalp, left side. Prescribed valacyclovir for 7 days.
There was some mild redness and swelling after the first shot. (01/2021).  Just mild soreness after the second shot (02/2021);  The third booster  (12/06/2021).  Lots of redness that spread from the injection spot down to her elbow.  It has subsided in the upper arm area, but now extends down her arm to below the elbow area (12/24/2021).  It is red and her arm seems warm.  She complains that her arm hurts.   No one ever asked if she was taking a blood thinner.  All three doses were the Moderna EUA.
Vaccine received 8/3/04 in the morning. Client described feeling dizzy 24 hours after receiving the vaccine. States equalibrium off, could not walk, was falling. Started vomiting the evening of 8/4/04. Continued to vomit during the day of 8/5/04. Dizziness continued. Father took her to the ER the evening of 8/5/04 and waited 6 hours to be seen.  Seen on 8/6/04 by M.D. and was diagnosed with LABYRINTHITIS and discharge by  D.R.N. with a prescription for Valium and instructions for bed rest.  Had follow up care in one week with primary care physican's office. For 2 days after ER visit was unable to walk due to dizziness and was 2 weeks before the dizziness was totally resolved.
Hives which started within 1 hour after the first dose of the COVID-19 Pfizer-BioTech vaccine was administered. Hives started on left arm and then spread throughout body, mostly on upper and lower extremities and trunk. Was seen and evaluated by a medical provider (nurse practitioner) 3/16/2021. Patient was diagnosed with urticarial rash (hives) and given prescription for cetirizine 10 mg 1 tab twice per day and Epipen to use in case of anaphylaxis.  There were no signs of anaphylaxis at time of exam on 3/16/2021.
Patient states that she within 5 minutes she felt it in her throat affecting her vocal cords making it difficut for her to talk, headache, cough, mucus, eyes became red and pus like pink eye. Was in bed for 3 days eating ice chips. Did not seek medical care.
weakness, muscle pains in legs, sore left and right arm, fever 100.3 for 24 hours, red swelling at injection area with rash continuing after 48 hours.
Covid Bivalent vaccine was given from a vial that had been opened on 4/21/23. No treatment required at this time. Outcome, patient notified by physician. Instructed to monitor for any symptoms or side effects from the vaccine and report back to Dr. According to the report from Pfizer, the vaccine efficacy is only good for 24 hours after initial puncture of the vial. Therefore the physician will decide if further boosters are indicated.
Patient had a legal complaint. An attorney reported that a male child received Acel-Imune vaccine (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) (date of immunization not specified). It is alleged that as a result of the exposure to mercury in the vaccine the child developed mercury poisoning. The child developed the following exposure; "severe" learning disabilities, impairments in social relatedness, language and communication difficulties, abnormal movements, sensory dysfunction, depressions, anxiety, hearing loss , severe bowel dysfunction, and other "severe" health disorders (not identified). This case was considered serious since these events were considered medically important in this case No further information was available as of the date of this report.
Mom states woke up about 4 1/2 hrs p/vax given; screamed for a week & had high fever for a week; pt tak en to hosp where adm & had MRI, EEG & x-rays; neck spasms from time to time & loss muscle tone in neck & head will roll & drop;
Extrene migraine, fever and uncontrollable vomiting one week after 3rd Pfizer booster for Covid. I anticipated low grade fever, mild headache and discomfort but when unexpected side effects escalated for a full week and left me unable to leave home (close proximity to bathroom) I thought it wise to share what other patients may anticipate.
Initial and follow-up information has been received from a health professional concerning a 64 year old male with elevated cholesterol, hypertension, hyperlipidemia, coronary artery disease and intervertebral disc degeneration and no drug allergies who on 17-OCT-2006, at 08:15, was vaccinated intramuscularly, in the right arm, with a first 0.5 ml dose of Pneumovax 23 (lot #651357/0391F).  Concomitant therapy included CRESTOR, VALIUM and FIORINAL.  Subsequently, on 17-OCT-2006, the patient experienced redness, swelling and pain of the right arm.  On the same day, the patient returned to the physician's office with a "silver dollar size mark" on her right upper arm that was sore and hot to touch.  The patient was given instructions to apply ice.  The patient returned to the physician's office when the mark became the size of a pancake.  The patient was instructed to take BENADRYL.  On 20-OCT-2007 the patient was given a prescription for Z-PAK.  Subsequently, the patient recovered.  There were no relevant diagnostic or laboratory tests performed.  Additional information has been requested.
This spontaneous report as received from a Licensed Practical Nurse via company representative refers to a patient of unknown age and gender. In 2013 (date unspecified) the patient was vaccinated with a dose of PNEUMOVAX 23, injection (strength, dose, route, lot number and expiration date not provided). The nurse reported that the patient had adverse reactions (type of reaction unspecified) with in the last couple of weeks (in 2013, date unspecified) following vaccination with PNEUMOVAX 23. The outcome of adverse event was not reported. The relatedness between vaccination with PNEUMOVAX 23 and adverse reactions was not reported. The adverse event had been provided to the Vaccine Adverse Event Reporting System (VAERS). This is one of two reports from the same source (#1312USA004888). Additional information has been requested.
DIZZY; FELT WEIRD; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number not reported) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 24-MAR-2021, the subject experienced dizzy. On 24-MAR-2021, the subject experienced felt weird. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dizzy and felt weird was not reported. This report was non-serious.
after receiving shot, I waited 30 min, because I had bells palsy in the past  (about 16 years ago) it was an extra pre caution, approximately an hour later I felt slight dizziness which was not a concern for me  and passed quickly.  approx 2 or so hours later i got a bad stomach cramp similar to a bad menstral cramp however I am menopausal so this was unusual.  I believe it happened 2 or 3 times, that afternoon and maybe once the following day but never again.  The next day after my vaccine 04/04 I experienced a very low fever, came and went most bothersome was the chill and tiredness i felt by evening,  by 04/05 every symptom was gone just a bit of sore arm.  I was away on vacation when I heard the news about the pause and was concerned because I had stomach cramps .  These cramps were just after the shot and came and went quickly so maybe not much of an issue.  Upon return from my vacation last night, I blew my nose and there was blood in my right nostril.  it was not a flowing blood and I think it may have just been caused by the dry air in the airplane?  it was approximately 5.5 hr flight.  Maybe not related but thought I would mention it.
This spontaneous report as received from a pharmacist via a company representative refers to a 61 year old female patient. On 24-OCT-2014 the patient was vaccinated with a dose of ZOSTAVAX (lot # K000994, expiration date 06-MAR-2015, 1 injection), subcutaneous in the left arm. On 24-OCT-2014, 8 hours after vaccination, the patient experienced moderate redness and swelling at the injection site that covered the tricep area of the left arm. The patient describes the irritated area as being three inches wide and 6 inches long. The patient also reported a bilateral tingling sensation in her lower extremity area on 24-OCT-2014. The patient did not seek medical attention and no treatment was given for the events. The outcome of the events was reported as recovered/resolved on an unspecified date in October 2014. No product quality complaint (PQC) involved. Additional information has been requested.
"Severe Vomiting and Diarrhea". Leg weakness and cramping. "Complete loss of appetite".
Nondescript abd pain - back sensation of tingling, crawling, hurting started 1 wk after administration and continues.
My dughter became very ill when we left the office. Complained of headache, stomache ache, had a fever, could not keep balance. Within 8 hrs I had to take her to ER, she was vomiting, temp of 101, she had dehydrated so bad they said her veins had colapsed. Dr. had checked her prior to the shot and she was fine. Also her throat had turned yellow, she was given an IV and sent home, where she stayed sick in bed not eating for 3 days.
PATIENT WAS ADMINISTERED A COVID MODERNA VACCINE 5 DAYS BEFORE THEY TURNED 18
Nurse practitioner called to be apart of the Pregnancy Registry.; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Nurse practitioner called to be apart of the Pregnancy Registry.) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-Oct-2020 and the estimated date of delivery was 08-Jul-2021. On 22-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Nurse practitioner called to be apart of the Pregnancy Registry.). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixteenth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 22-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Nurse practitioner called to be apart of the Pregnancy Registry.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
1.  Left side of face became partially numb while driving home from pharmacy-lasted 20-30 minutes.  2.  Insomnia returned as well as some nausea and pain left, back of head during the night.
low grade fever; chills; body ache; joint pain; This spontaneous case was reported by a physician and describes the occurrence of CHILLS (chills), MYALGIA (body ache), ARTHRALGIA (joint pain) and PYREXIA (low grade fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced CHILLS (chills), MYALGIA (body ache) and ARTHRALGIA (joint pain). On an unknown date, the patient experienced PYREXIA (low grade fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, CHILLS (chills), MYALGIA (body ache), ARTHRALGIA (joint pain) and PYREXIA (low grade fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   As concomitant medication she reported consuming Thyroid medicine. No information regarding corrective treatment was reported by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Outcome updated as report and patient took second dose without adverse reaction and doesnot consent to further fUs.
Metallic taste, palpitations, nausea, dizziness, flush Subsided after 30 min headache 4 hours later Tylenol taken  Next day painful injection site,  body aches chills fatigue  Tylenol Advil taken with some relief
Uncomfortable with covid- had booster--as does family; Uncomfortable with covid- had booster--as does family; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a Pfizer sponsored program (060820).  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single and administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "breast cancer" (unspecified if ongoing). Concomitant medication(s) included: IBRANCE taken for breast cancer female, start date: 03Jun2021 (ongoing); ANASTROZOLE; XGEVA. The following information was reported: Patient was uncomfortable with COVID- had booster as does family. Pandemic causes her stress. The outcome of events was unknown.    The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events drug ineffective and covid-19 and BNT162B2.
Patient received PedvaxHIB, lot 0915N, via airgun in her right thigh 12/22/04. Subsequently developed cellulitis requiring IV antibiotics. Follow up 01/20/05: 2 days after receiving immunizations had swelling and redness that got severly worse and required Iv antibiotics for resolution (Cellulitis).
pt recv vax & exp severe autoimmune reaction to vax; described the pt exp as lupus like autoimmune & optic neuritis sx'
Erythema Multiforme lesion 3.5" x 2" with red edge, clear center, L deltoid, painful and swollen
a lot of tingling in lips; Felt like she had gotten a dental block and was just coming out of it; numbness; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (a lot of tingling in lips), DENTAL DISCOMFORT (Felt like she had gotten a dental block and was just coming out of it) and HYPOAESTHESIA (numbness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included Lip augmentation (in march 2020). Concomitant products included Estrogen Patch, Toprolol XL, ACETYLSALICYLIC ACID (BABY ASPIRIN), CELECOXIB (CELEBREX) and MONTELUKAST for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced PARAESTHESIA ORAL (a lot of tingling in lips), DENTAL DISCOMFORT (Felt like she had gotten a dental block and was just coming out of it) and HYPOAESTHESIA (numbness). At the time of the report, PARAESTHESIA ORAL (a lot of tingling in lips) and DENTAL DISCOMFORT (Felt like she had gotten a dental block and was just coming out of it) outcome was unknown and HYPOAESTHESIA (numbness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included NONE   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt received dose #1 of the Moderna COVID19 vaccine. Within minutes of sitting down in observation the pt began to feel light headed and very sweaty. Pt was laid down on a cot, BP was 110/80, HR 77, O2sat 98%. EMS on site and performed evaluation. Pt recovered within 10 minutes. Pt did not lose consciousness. Pt stated this happened to him before when he had lidocaine at the dentist. Pt signed refusal for transport to the hospital. Pt was advised to contact his PCP to discuss what happened and to arrange to have his second dose in a medical facility. Pt verbalized understanding.
Child started with rash over body, some wheals and itching approx. 12-24 hrs post shots. No breathing problems noted. Child was seen by doctor and given medication with follow-up visit in 2 days.
Patient was given vaccine on 5/2/22 from vial which had been first punctured 5/1/22 roughly 30 hours prior and left at room temperature for roughly 30 hours. Attempted to speak to patient at 243pm 5/3/22 to ask about patient's condition, but patient did not answer, so a voicemail was left asking him to call the pharmacy back as soon as able. There has been no call back as of the time of writing this report.